{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:31:13Z","timestamp":1780428673866,"version":"3.54.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>Uterine leiomyomas (ULs) are common benign tumors affecting women of different ethnicities. A large proportion of UL has mutations in <jats:italic toggle=\"yes\">MED12<\/jats:italic>. Multiple and solitary ULs usually manifest with different severities, suggesting that their origin and growth pattern may be driven by different molecular mechanisms. Here, we compared the frequency and the spectrum of <jats:italic toggle=\"yes\">MED12<\/jats:italic> exon 2 mutations between multiple (n=82) and solitary (n=40) ULs from Russian patients. Overall, we detected <jats:italic toggle=\"yes\">MED12<\/jats:italic> exon 2 mutations in 51.6% (63\/122) of ULs. The frequency of <jats:italic toggle=\"yes\">MED12<\/jats:italic> exon 2 mutations was almost two-fold higher in samples from the multiple UL patients than in those from the solitary UL patients \u2013 61% (50\/82) versus 32.5% (13\/40). The increased <jats:italic toggle=\"yes\">MED12<\/jats:italic> exon 2 mutation frequency in the multiple ULs was not accompanied by significant alterations in the spectrum of mutation categories, which included missense mutations, deletions, splicing defects, and multiple (double\/triple) mutations. Each mutation category had a unique mutation set, comprising both frequent and rarely encountered mutations, which did and did not overlap between the studied groups, respectively. We conclude that in contrast to the solitary ULs, the multiple ULs predominantly originate through <jats:italic toggle=\"yes\">MED12-<\/jats:italic>associated mechanisms. The nature of these mechanisms seems to be similar in solitary and multiple ULs, as they contain similar mutations. In multiple UL patients, they are likely to be nonsporadic, indicating the existence of specific factors predisposing to multiple UL development. These data suggest that to clearly understand UL pathogenesis, solitary and multiple tumors should probably be analyzed as separate sets.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000255","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T18:33:17Z","timestamp":1449081197000},"page":"509-515","source":"Crossref","is-referenced-by-count":31,"title":["Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients"],"prefix":"10.1097","volume":"35","author":[{"given":"Natalia S.","family":"Osinovskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Malysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Yu.","family":"Shved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana E.","family":"Ivashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskender Yu.","family":"Sultanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Efimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Yarmolinskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly F.","family":"Bezhenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav S.","family":"Baranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/14767058.2014.921675","article-title":"Number and size of uterine fibroids and obstetric outcomes","volume":"28","author":"Ciavattini","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-20230824","first-page":"483","article-title":"Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis","volume":"41","author":"Kjerulff","year":"1996","journal-title":"J Reprod Med"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am J Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.08.025","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma","volume":"158","author":"Sandberg","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"27137","DOI":"10.1074\/jbc.273.42.27137","article-title":"ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases","volume":"273","author":"Quintana","year":"1998","journal-title":"J Biol Chem"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-4608(02)00547-2","article-title":"PCOLCE deletion and expression analyses in uterine leiomyomata","volume":"137","author":"Ligon","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.22001","article-title":"Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma","volume":"52","author":"Schoenmakers","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fmed.2015.00015","article-title":"High mobility group A proteins as tumor markers","volume":"2","author":"Pallante","year":"2015","journal-title":"Front Med"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen","year":"2011","journal-title":"Science"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids \u2013 their relationship to cytogenetic subgroups","volume":"131","author":"Markowski","year":"2012","journal-title":"Int J Cancer"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0000000000000096","article-title":"Uterine fibroids: do we deal with more than one disease?","volume":"33","author":"Markowski","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.2870110102","article-title":"Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberration in the development of leiomyomata","volume":"7","author":"Mashal","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajog.2005.02.097","article-title":"Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis","volume":"193","author":"Canevari","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.humpath.2006.05.005","article-title":"Use o X chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma","volume":"37","author":"Zhang","year":"2006","journal-title":"Hum Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","article-title":"Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids","volume":"290","author":"Halder","year":"2015","journal-title":"Mol Genet Genomics"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"966","DOI":"10.18632\/oncotarget.370","article-title":"MED12 exon 2 mutations are common in uterine leiomyomas from South African patients","volume":"2","author":"M\u00e4kinen","year":"2011","journal-title":"Oncotarget"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/ijc.27610","article-title":"Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors","volume":"131","author":"Je","year":"2012","journal-title":"Int J Cancer"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3892\/ol.2015.3118","article-title":"MED12 mutation in patients with hysteromyoma","volume":"9","author":"Ye","year":"2015","journal-title":"Oncol Lett"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","article-title":"MED12 mutation frequency in unselected sporadic uterine leiomyomas","volume":"102","author":"Heinonen","year":"2014","journal-title":"Fertil Steril"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.humpath.2013.01.006","article-title":"Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity","volume":"44","author":"De Graaff","year":"2013","journal-title":"Hum Pathol"},{"key":"R25-20230824","first-page":"dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"pii","author":"Commandeur","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(00)00160-2","article-title":"Heritability and risk factors of uterine fibroids - the Finnish Twin Cohort study","volume":"37","author":"Luoto","year":"2000","journal-title":"Maturitas"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2009.12.072","article-title":"Solitary and multiple uterine leiomyomas among Caucasian women: two different disorders?","volume":"94","author":"Pakiz","year":"2010","journal-title":"Fertil Steril"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.semcdb.2011.07.024","article-title":"Mediator and Human Disease","volume":"22","author":"Spaeth","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8166-6-23","article-title":"Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability","volume":"6","author":"Markowski","year":"2013","journal-title":"Mol Cytogenet"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","article-title":"Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity","volume":"7","author":"Turunen","year":"2014","journal-title":"Cell Rep"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"e40015","DOI":"10.1371\/journal.pone.0040015","article-title":"MED12 alterations in both human benign and malignant uterine soft tissue tumors","volume":"7","author":"P\u00e9rot","year":"2012","journal-title":"PLoS One"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1134\/S1022795413120089","article-title":"MED12 gene mutations in women with uterine myoma","volume":"49","author":"Osinovskaya","year":"2013","journal-title":"Russ J Genet"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2013.08.005","article-title":"MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors","volume":"45","author":"Schwetye","year":"2014","journal-title":"Hum Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201611000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:26:16Z","timestamp":1692840376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201611000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000255","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}